Baxter International, Inc.

931 articles with Baxter International, Inc.

• Baxter International Inc. to Host Webcast of Annual Meeting of Stockholders

  4/2/2018

  Baxter International, Inc. will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 8, 2018 at 9:00 a.m. Central Time.

• 

  The Big Tease: Takeda Considers Buying Shire

  3/28/2018

  Shire stock prices jumped up to 26 percent on rumors that Takeda Pharmaceuticals was considering a buyout.

• Baxter Completes Acquisition of RECOTHROM and PREVELEAK to Broaden Surgical Hemostat and Sealant Portfolio

  3/19/2018

  RECOTHROM Thrombin topical (Recombinant) is the first and only stand-alone recombinant thrombin and PREVELEAK Surgical Sealant is used in vascular reconstruction.

• Baxter Declares Quarterly Dividend and Announces Expanded Share Repurchase Authorization

  2/20/2018

  Baxter International Inc. (NYSE:BAX) today announced a quarterly cash dividend and an expanded authorization for its share repurchase program.

• Baxter to Present at the Raymond James & Associates 39th Annual Institutional Investors Conference

  2/7/2018

  Baxter will present at the Raymond James & Associates 39th Annual Institutional Investors Conference on Tuesday, March 6, 2018, in Orlando, Fla. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 4:35 p.m. EST.

• Baxter Reports 2017 Fourth-Quarter and Full-Year Results

  2/1/2018

  Baxter International, Inc. today reported results for the fourth quarter and full-year ended December 31, 2017, and provided its financial guidance for 2018.

• Baxter Announces U.S. FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin

  1/22/2018

  Baxter announced the U.S. Food and Drug Administration (FDA) approval of Bivalirudin in 0.9 percent Sodium Chloride Injection (bivalirudin).

• 

  Puma Hits a Huge Roadblock

  1/17/2018

  Despite some safety concerns such as severe diarrhea, the FDA approved Puma's breast cancer drug Nerlynx in July 2017.

• Baxter Launches Arisure Closed System Transfer Device to Help Prevent Hazardous Drug Exposure and Maintain Medication Sterility

  1/11/2018

  Baxter today announced a distribution agreement for the U.S. launch of the Arisure Closed System Transfer device.

• Baxter to Host Fourth Quarter 2017 Financial Results Conference Call for Investors

  1/10/2018

  Baxter will host a conference call to discuss its fourth quarter 2017 financial results on Thursday, February 1, 2018, at 7:30 a.m. Central Standard Time.

• Baxter Announces Agreement to Broaden Portfolio of Innovative Surgical Products

  1/8/2018

  Baxter announced an agreement to acquire two hemostat and sealant products from Mallinckrodt plc: RECOTHROM Thrombin topical (Recombinant), the first and only stand-alone recombinant thrombin, and PREVELEAK Surgical Sealant, which is used in vascular reconstruction.

• Baxter Declares Quarterly Dividend

  11/14/2017

  The dividend is payable on January 2, 2018, to stockholders of record as of December 1, 2017. The indicated annual dividend rate is $0.64 per share.

• Baxter Presents Data on the Role of SHARESOURCE Telehealth Platform in Helping the Clinical Management of Peritoneal Dialysis Patients

  11/7/2017

  Presented at the American Society of Nephrology’s annual Kidney Week Congress, Oct. 31- Nov. 5, the exploratory studies show how SHARESOURCE data may provide an early indicator of impending peritonitis, or evidence of PD catheter dysfunction.

• Baxter Highlights New Clinical Data Showing HDx Enabled by THERANOVA Removes Mid-Sized Uremic Toxins During Dialysis

  11/6/2017

  The studies were conducted by clinicians in the United Kingdom and Germany, and were presented at the American Society of Nephrology’s annual Kidney Week Congress, Oct. 31-Nov. 5.

• Baxter Supports 27 Abstract Presentations at ASN Kidney Week to Advance Scientific Exchange Focused on New Standards of Renal Care

  11/3/2017

  Baxter today announced the presentation of 27 abstracts at the American Association of Nephrology (ASN) Kidney Week, Oct. 31 - Nov. 5, to support greater scientific exchange across the continuum of renal care.

• Baxter Launches PD-First Program for Employees and Families

  11/1/2017

  Baxter announced a new PD-first program for its employees and family members aimed at improving education and awareness of dialysis treatment options, including peritoneal dialysis (PD).

• Baxter Reports Third-Quarter 2017 Results and Updates Financial Outlook for Full-Year 2017

  10/25/2017

  Baxter International Inc. today reported results for the third quarter of 2017 and updated its financial outlook for full-year 2017.

• Baxter International Provides Update On Puerto Rico Recovery Status Post Hurricane Maria

  10/13/2017

• Baxter International Expects Hit on Q4 Revenue Due to Hurricane Maria

  10/13/2017

• Baxter International To Host Third Quarter 2017 Financial Results Conference Call For Investors

  9/29/2017